- Home
- JDZG vs RNAZ Comparison
JDZG vs RNAZ Comparison
Compare JDZG & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- RNAZ
- Stock Information
- Founded
- JDZG 2020
- RNAZ 2016
- Country
- JDZG China
- RNAZ United States
- Employees
- JDZG N/A
- RNAZ N/A
- Industry
- JDZG Other Consumer Services
- RNAZ Biotechnology: Pharmaceutical Preparations
- Sector
- JDZG Real Estate
- RNAZ Health Care
- Exchange
- JDZG Nasdaq
- RNAZ Nasdaq
- Market Cap
- JDZG 7.5M
- RNAZ 6.1M
- IPO Year
- JDZG 2024
- RNAZ 2021
- Fundamental
- Price
- JDZG $1.86
- RNAZ $10.79
- Analyst Decision
- JDZG
- RNAZ Strong Buy
- Analyst Count
- JDZG 0
- RNAZ 1
- Target Price
- JDZG N/A
- RNAZ $280.00
- AVG Volume (30 Days)
- JDZG 131.2K
- RNAZ 249.9K
- Earning Date
- JDZG 08-26-2025
- RNAZ 08-14-2025
- Dividend Yield
- JDZG N/A
- RNAZ N/A
- EPS Growth
- JDZG N/A
- RNAZ N/A
- EPS
- JDZG 0.25
- RNAZ N/A
- Revenue
- JDZG $2,567,741.00
- RNAZ N/A
- Revenue This Year
- JDZG N/A
- RNAZ N/A
- Revenue Next Year
- JDZG N/A
- RNAZ N/A
- P/E Ratio
- JDZG $7.43
- RNAZ N/A
- Revenue Growth
- JDZG 20.36
- RNAZ N/A
- 52 Week Low
- JDZG $1.58
- RNAZ $6.15
- 52 Week High
- JDZG $21.28
- RNAZ $739.20
- Technical
- Relative Strength Index (RSI)
- JDZG N/A
- RNAZ 51.01
- Support Level
- JDZG N/A
- RNAZ $10.45
- Resistance Level
- JDZG N/A
- RNAZ $11.75
- Average True Range (ATR)
- JDZG 0.00
- RNAZ 1.05
- MACD
- JDZG 0.00
- RNAZ -0.13
- Stochastic Oscillator
- JDZG 0.00
- RNAZ 16.45
About JDZG JIADE LIMITED Common stock
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.